Evi1 | List of Frontiers open access articles

Review

Published on 16 Feb 2026

The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis

in Cancer Immunity and Immunotherapy

Yuchao Hao
Jing Liu
Jiacheng Lou
Jinsong Yan

Frontiers in Immunology

doi 10.3389/fimmu.2026.1750231

236 views

Original Research

Published on 13 Jan 2026

Low EVI1 expression at diagnosis identifies a high-risk subgroup in adult Ph-negative B-cell acute lymphoblastic leukemia

in Hematology

Shu Kong
Xu Wang
Wen-Min Chen
Ling-Di Li
Yue Hao
Jin-Ying Li
Dai-Hong Xie
Zhao-Yu Li
Yue-Yun Lai
Hao Jiang

Frontiers in Medicine

doi 10.3389/fmed.2025.1701539

701 views

Case Report

Published on 19 Jan 2026

A rare cytogenetically cryptic MECOM rearrangement in a patient with myelodysplastic neoplasm and SF3B1 mutation identified by RNA sequencing: a case report

in Hematologic Malignancies

Ye Jin
Zi-Jun Xu
Chao-Ran Lv
Zhen Qian
Xiang-Mei Wen
Sheng Xiao
Jiang Lin
Jun Qian

Frontiers in Oncology

doi 10.3389/fonc.2026.1742267

654 views

Original Research

Published on 13 Sep 2021

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia

in Hematologic Malignancies

Yongzhi Zheng
Yan Huang
Shaohua Le
Hao Zheng
Xueling Hua
Zaisheng Chen
Xiaoqin Feng
Chunfu Li
Mincui Zheng
Honggui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.712747

4,781 views
8 citations

Case Report

Published on 04 Apr 2025

Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature

in Cancer Genetics

Soumya Mikkilineni
Juan Pablo Pineda-Reyes
Lindsay Wilde
Andres Ferber
Zi-Xuan Wang
Stephen Peiper
Guldeep Uppal
Jerald Gong
Jinglan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1526044

2,471 views
2 citations

Original Research

Published on 12 Feb 2013

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient

in Pharmacology of Anti-Cancer Drugs

Torsten Holm Nielsen
Nathalie Johnson
Nicolas Garnier
Stanley Kwan
Lu Yao
Eftihia Cocolakis
Josée Hébert
Robert A. Morgan
Éric Paquet
Kevin P. Callahan

Frontiers in Pharmacology

doi 10.3389/fphar.2013.00009

6,667 views
5 citations

Case Report

Accepted on 11 Feb 2026

Therapy-Related Acute Myeloid Leukemia Following Successful Treatment of High-Risk Neuroblastoma in a Pediatric Patient: A Case Report and Insights into Late Complications

in Pediatric Oncology

Sijia He
Ju Gao
Lina Qiao
Guoqian He
Xia Guo
XiaoYu Jing

Frontiers in Oncology

360 views

Original Research

Published on 31 Jan 2022

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma

in Thoracic Oncology

Meng Li
Hui Ren
Yanpeng Zhang
Na Liu
Meng Fan
Ke Wang
Tian Yang
Mingwei Chen
Puyu Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.772686

8,612 views
17 citations

Articles

The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis

Low EVI1 expression at diagnosis identifies a high-risk subgroup in adult Ph-negative B-cell acute lymphoblastic leukemia

A rare cytogenetically cryptic MECOM rearrangement in a patient with myelodysplastic neoplasm and SF3B1 mutation identified by RNA sequencing: a case report

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia

Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient

Therapy-Related Acute Myeloid Leukemia Following Successful Treatment of High-Risk Neuroblastoma in a Pediatric Patient: A Case Report and Insights into Late Complications

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma